Clinical Trial Update: Long Term Use Of Xalacom In Patients Glaucoma Or Ocular Hypertension

View source ↗

Summary

A long-term trial update on the use of Xalacom in patients with glaucoma or ocular hypertension, with completed status and results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Xalacom (latanoprost/timolol)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Glaucoma, Ocular Hypertension | Status: COMPLETED | Results posted: 2017-07-17